210 results
6-K
TAK
Takeda Pharmaceutical Co
17 Jun 24
Current report (foreign)
6:46am
Primary Endpoint of Reduction in Major Motor Drop Seizures
Soticlestat Showed a Consistent and Favorable Safety and Tolerability Profile in Both … .
Soticlestat was generally well tolerated in both SKYLINE and SKYWAY studies and demonstrated a safety profile consistent with the findings of previous studies
6-K
TAK
Takeda Pharmaceutical Co
7 Jun 24
Current report (foreign)
6:07am
or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic
6-K
TAK
Takeda Pharmaceutical Co
7 Jun 24
Current report (foreign)
6:04am
or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus
6-K
TAK
Takeda Pharmaceutical Co
3 Jun 24
Current report (foreign)
6:45am
Orexin Receptor 2 Agonist to Potentially Address the Underlying Pathophysiology of NT1
– Safety Results Indicated TAK-861 is Generally Safe and Well … and were transient.
"In this trial, TAK-861's profile balanced efficacy and safety with the potential to establish a new standard of care for people
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
versus the first generation TYK2 inhibitor already approved in moderate-to-severe plaque psoriasis. In FY2023, we demonstrated strong efficacy and safety … and obtain addi�onal informa�on on safety and efficacy, leading to more rapid development and delivery of treatments. The U.S. FDA approval of GammaGard
6-K
EX-99.1
c34sken
29 May 24
Current report (foreign)
6:29am
6-K
EX-99.1
ubvwzwfod 0h42
29 May 24
Current report (foreign)
6:24am
6-K
EX-99.1
qi0 lmpczd4zanbv7
9 May 24
Current report (foreign)
6:08am
6-K
r4mjr foa
9 May 24
Current report (foreign)
6:03am
6-K
n2bw4ts3p03a1wks
9 May 24
Current report (foreign)
6:02am
6-K
EX-99.1
9osd40vi
9 May 24
Current report (foreign)
6:01am
6-K
EX-99.1
n9gv0
19 Apr 24
Current report (foreign)
6:12am
6-K
gtwzmkl2d6rgc07x
15 Apr 24
Current report (foreign)
6:02am
6-K
8679v04
9 Feb 24
Current report (foreign)
6:03am
6-K
47tzt
2 Feb 24
Current report (foreign)
6:16am
6-K
f7fshh ubp
1 Feb 24
Current report (foreign)
6:18am
6-K
EX-99.1
vaychdikjftchndn57g
1 Feb 24
Current report (foreign)
6:06am
6-K
2pc8pcla3rrk31
16 Jan 24
Current report (foreign)
6:01am
6-K
EX-99.1
tt91ac h3dpv745pgx
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
dt8ep8g 73r
30 Nov 23
Current report (foreign)
6:01am